Recently, it was reported that alternative splicing regulates cervical cancer oncogenesis via miL1RAP-NF-κB-CD47 axis, indicative of an attractive therapeutic target for treatment of cervical cancer [22]. The gene discussed is CD47; the disease is cervical cancer.